Cisplatin for Sarcoids, Carcinomas

Laurie R. Goodrich, DVM, MS, of Cornell University, described the benefits of injecting Cisplatin mixed in an oily emulsion to treat sarcoids and squamous cell carcinomas. She presented her findings at the recent American Association of Equine Practitioners convention. Cisplatin is a heavy metal compound that stops cell division and causes cell death. It has been used by intratumoral (into the tumor) injection in the treatment of sarcoids with an 87% success rate, and in the treatment of squamous cell carcinomas with a 65% success rate.

Goodrich said the procedure is safe, causes minimal local wound toxicosis, and does not affect the healing of surgical incisions. Surgical debridement can be combined with the injections to lower the cost and number of injections needed. Goodrich said that success depends on owner complianc with and commitment to the protocol.

About the Author

Sarah Evers Conrad

Sarah Evers Conrad has a bachelor’s of arts in journalism and equine science from Western Kentucky University. As a lifelong horse lover and equestrian, Conrad started her career at The Horse: Your Guide to Equine Health Care magazine. She has also worked for the United States Equestrian Federation as the managing editor of Equestrian magazine and director of e-communications and served as content manager/travel writer for a Caribbean travel agency. When she isn’t freelancing, Conrad spends her free time enjoying her family, reading, practicing photography, traveling, crocheting, and being around animals in her Lexington, Kentucky, home.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners